Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Tackling multidrug-resistant gonorrhea: how should we prepare for the untreatable?

Kidd S, Kirkcaldy R, Weinstock H, Bolan G.

Expert Rev Anti Infect Ther. 2012 Aug;10(8):831-3. doi: 10.1586/eri.12.69. No abstract available.

PMID:
23030318
2.
3.

Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Ison CA, Hussey J, Sankar KN, Evans J, Alexander S.

Euro Surveill. 2011 Apr 7;16(14). pii: 19833.

4.

Prospects of untreatable gonorrhea and ways forward.

Whiley DM, Lahra MM, Unemo M.

Future Microbiol. 2015;10(3):313-6. doi: 10.2217/fmb.14.138. No abstract available.

PMID:
25812453
5.

Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.

Whiley DM, Jacobsson S, Tapsall JW, Nissen MD, Sloots TP, Unemo M.

J Antimicrob Chemother. 2010 Dec;65(12):2543-7. doi: 10.1093/jac/dkq377. Epub 2010 Oct 12.

PMID:
20940180
6.

Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.

7.

[Antimicrobial resistance in Neisseria gonorrheae in North-East Romania].

Bădescu AC, Petrescu Z, Enache A, Buiuc D.

Rev Med Chir Soc Med Nat Iasi. 2007 Apr-Jun;111(2):512-5. Romanian.

PMID:
17983194
8.

Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.

Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, Kitawaki J.

Emerg Infect Dis. 2011 Jan;17(1):148-9. doi: 10.3201/eid1701.100397. No abstract available.

9.

Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.

Tzelepi E, Daniilidou M, Miriagou V, Siatravani E, Pavlidou E, Flemetakis A.

J Antimicrob Chemother. 2008 Sep;62(3):637-9. doi: 10.1093/jac/dkn236. Epub 2008 Jun 12. No abstract available.

PMID:
18556708
10.

Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.

Chisholm SA, Alexander S, Desouza-Thomas L, Maclure-Webster E, Anderson J, Nichols T, Lowndes CM, Ison CA; GRASP Collaborative Group.

J Antimicrob Chemother. 2011 Nov;66(11):2509-12. doi: 10.1093/jac/dkr332. Epub 2011 Aug 16.

PMID:
21846672
11.

Antimicrobial sensitivity of Neisseria gonorrhoeae: a hospital-based study from Kuwait.

Sharma AK, Al-Mutairi N, Zaki A, Nour-Eldin O, Joshi A, Rijhwani M, Al-Tayeh MY, Sultan AM.

J Chemother. 2005 Feb;17(1):117-8. No abstract available.

PMID:
15828455
12.

Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988 and 1989.

Centers for Disease Control (CDC).

MMWR Morb Mortal Wkly Rep. 1990 May 4;39(17):284-7, 293. No abstract available.

PMID:
2139166
13.

Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.

Wang SA, Lee MV, O'Connor N, Iverson CJ, Ohye RG, Whiticar PM, Hale JA, Trees DL, Knapp JS, Effler PV, Weinstock HS.

Clin Infect Dis. 2003 Sep 15;37(6):849-52. Epub 2003 Aug 28.

PMID:
12955650
14.

First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.

Carnicer-Pont D, Smithson A, Fina-Homar E, Bastida MT; Gonococcus Antimicrobial Resistance Surveillance Working Group.

Enferm Infecc Microbiol Clin. 2012 Apr;30(4):218-9. doi: 10.1016/j.eimc.2011.11.010. Epub 2012 Jan 14. No abstract available.

PMID:
22244992
15.
16.

[Antibiotic susceptibility of Neisseria gonorrhoeae in Guadalajara area].

Arias M, Tena D, Bisquert J.

Rev Esp Quimioter. 2011 Mar;24(1):48-9. Spanish. No abstract available.

17.

Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.

Kidd S, Lee MV, Maningas E, Komeya A, Kunimoto G, O'Connor N, Katz AR, Wasserman GM, Kirkcaldy RD, Whelen AC.

Sex Transm Dis. 2013 Sep;40(9):756-9. doi: 10.1097/01.olq.0000431357.18959.30.

18.

Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.

Bala M, Ray K, Gupta SM, Muralidhar S, Jain RK.

J Antimicrob Chemother. 2007 Sep;60(3):582-6. Epub 2007 Jun 29.

PMID:
17604320
19.

Cephalosporin resistance in gonorrhoea.

Wright DJ, Azadian B.

Lancet Infect Dis. 2013 Sep;13(9):728-30. doi: 10.1016/S1473-3099(13)70161-0. Epub 2013 Jun 11. No abstract available.

PMID:
23764301
20.

Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.

Ison CA, Alexander S.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):867-76. doi: 10.1586/eri.11.103. Review.

PMID:
21973299

Supplemental Content

Support Center